James J. Rusthoven
Eli Lilly (United States) · 94 works · 6,020 citations · h-index 29
Top works
- Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma
- Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. National Cancer Institute of Canada Clinical Trials Group.
- Multitargeted Antifolate LY231514 as First-Line Chemotherapy for Patients With Advanced Non–Small-Cell Lung Cancer: A Phase II Study
- Homocysteine and methylmalonic acid: markers to predict and avoid toxicity from pemetrexed therapy.
- Phase II study of pemetrexed disodium, a multitargeted antifolate, and cisplatin as first-line therapy in patients with advanced nonsmall cell lung carcinoma
- Use of dexamethasone and granisetron in the control of delayed emesis for patients who receive highly emetogenic chemotherapy. National Cancer Institute of Canada Clinical Trials Group.
- Phase II Study of Pemetrexed With and Without Folic Acid and Vitamin B12 as Front-Line Therapy in Malignant Pleural Mesothelioma
- Differentiation of Thy 1-bearing cells from progenitors in long-term bone marrow cultures.
- Impact of chemotherapy-associated nausea and vomiting on patients' functional status and on costs: survey of five Canadian centres.
- Varicella-zoster infection in adult cancer patients. A population study
- Superiority of Granisetron to Dexamethasone Plus Prochlorperazine in the Prevention of Chemotherapy-Induced Emesis
- Dexamethasone improves the efficacy of granisetron in the first 24 h following high-dose cisplatin chemotherapy
- Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma
- Malignant Pleural Mesothelioma
- Systemic infection by Rhodotorula spp. in the immunocompromised host
- A rapid and simple method for the purification of tumor cells from ascitic fluid of ovarian carcinoma
- Combination chemotherapy with bleomycin, etoposide, and cisplatin in metastatic non-small-cell lung cancer.
- Inconsistency of prognostic factors for post-chemotherapy nausea and vomiting
- Lung cancer practice guidelines: lessons learned and issues addressed by the Ontario Lung Cancer Disease Site Group.
- Adapting the Lung Cancer Symptom Scale (LCSS) to mesothelioma